Article · 28 Feb 2025
Research articlePublished 3 May 2019
Development and validation of stability indicating method for the estimation of pazopanib hydrochloride in pharmaceutical dosage forms by RP-HPLC
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A stability indicating reverse phase high performance liquid chromatography (RP-HPLC) method was developed and validated in pharmaceutical dosage form using Inertsil C18 (250mm × 4.6mm, 5m) column in isocratic mode with a mobile phase consisting of 0.1% ortho phosphoric acid and acetonitrile in the ratio 55:45 (%v/v). The detection was monitored using PDA detector at 269nm with a flow rate of 1mL/min and the column oven temperature was maintained at 30ºC. The retention time was found to be 5.1mins. A good linear response was observed in the concentration range of 25μg/mL – 150μg/mL with a correlation coefficient of 0.999. The method was validated as per ICH guidelines. Pazopanib hydrochloride was subjected to stress conditions including acidic, alkaline, oxidation, photolysis, thermal and neutral degradation, and the results showed that the net degradation was found to be within the limits.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Der Pharmacia Lettre.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Renju Prabhakaran”
- BylineArticles whose byline prints “Janakiraman K.”
- BylineArticles whose byline prints “Jyoti Harindran”